[go: up one dir, main page]

AR044246A1 - Vectores y celulas para la preparacion de composiciones inmunoprotectoras derivadas de plantas transgenicas - Google Patents

Vectores y celulas para la preparacion de composiciones inmunoprotectoras derivadas de plantas transgenicas

Info

Publication number
AR044246A1
AR044246A1 ARP040101521A ARP040101521A AR044246A1 AR 044246 A1 AR044246 A1 AR 044246A1 AR P040101521 A ARP040101521 A AR P040101521A AR P040101521 A ARP040101521 A AR P040101521A AR 044246 A1 AR044246 A1 AR 044246A1
Authority
AR
Argentina
Prior art keywords
preparation
vectors
cells
immunoprotector
transgenic plants
Prior art date
Application number
ARP040101521A
Other languages
English (en)
Original Assignee
Dow Agrosciences Llc
Thompson Boyce Plant Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Agrosciences Llc, Thompson Boyce Plant Res filed Critical Dow Agrosciences Llc
Publication of AR044246A1 publication Critical patent/AR044246A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente se refiere a la producción de vectores y métodos útiles para la preparación de células de plantas genéticamente transformadas que expresan inmunógenos de organismos patógenos los cuales son utilizados para producir partículas inmunoprotectoras útiles en la preparación de vacunas, incluye genes vegetales optimizados que codifican la proteína HN del virus de la enfermedad de Newcastle, también se refiere a métodos de producción de un antígeno en una planta transgénica. Reivindicación 1: Una secuencia nucleotídica optimizada vegetal aislada que codifica el antígeno HN del virus de la enfermedad de Newcastle que comprende la secuencia de SEQ ID Nº:1.
ARP040101521A 2003-05-05 2004-05-05 Vectores y celulas para la preparacion de composiciones inmunoprotectoras derivadas de plantas transgenicas AR044246A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46799803P 2003-05-05 2003-05-05

Publications (1)

Publication Number Publication Date
AR044246A1 true AR044246A1 (es) 2005-09-07

Family

ID=33435152

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040101521A AR044246A1 (es) 2003-05-05 2004-05-05 Vectores y celulas para la preparacion de composiciones inmunoprotectoras derivadas de plantas transgenicas

Country Status (13)

Country Link
US (3) US7132291B2 (es)
EP (1) EP1620550B1 (es)
KR (1) KR20060035596A (es)
CN (1) CN100393870C (es)
AR (1) AR044246A1 (es)
AT (1) ATE473271T1 (es)
AU (1) AU2004235813B2 (es)
BR (1) BRPI0410340A (es)
CA (1) CA2524293A1 (es)
DE (1) DE602004028004D1 (es)
NZ (1) NZ543348A (es)
WO (1) WO2004098533A2 (es)
ZA (1) ZA200508930B (es)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2526720C (en) 2003-05-22 2013-10-22 Fraunhofer Usa, Inc. Recombinant carrier molecule for expression, delivery and purification of target polypeptides
CN1326998C (zh) * 2004-11-25 2007-07-18 中国农业科学院哈尔滨兽医研究所 编码h5亚型禽流感病毒血凝素蛋白的基因及其应用
CN101378781B (zh) 2005-08-03 2013-08-07 美国弗劳恩霍夫股份有限公司 制造免疫球蛋白的组合物和方法
AU2006312126A1 (en) 2005-11-04 2007-05-18 Dow Agrosciences Llc Preparation of vaccine master cell lines using recombinant plant suspension cultures
EP1984405A4 (en) * 2006-02-13 2010-06-30 Fraunhofer Usa Inc INFLUENZA ANTIGENES, VACCINE COMPOSITIONS AND RELATED METHODS
CA2642056A1 (en) * 2006-02-13 2007-08-23 Fraunhofer Usa, Inc. Hpv antigens, vaccine compositions, and related methods
US8277816B2 (en) * 2006-02-13 2012-10-02 Fraunhofer Usa, Inc. Bacillus anthracis antigens, vaccine compositions, and related methods
EP2010210A4 (en) * 2006-04-21 2010-07-21 Dow Agrosciences Llc VACCINE AGAINST BIRD FLUID AND METHOD OF APPLICATION THEREFOR
KR100766775B1 (ko) * 2006-04-24 2007-11-01 대한민국 장출혈성대장균(ｅｈｅｃ) 감염증 예방용 톡소이드 백신
CN100487119C (zh) * 2006-05-09 2009-05-13 中国农业科学院哈尔滨兽医研究所 表达禽流感病毒H5亚型HA蛋白的重组新城疫LaSota弱毒疫苗株
AU2007261196A1 (en) * 2006-06-16 2007-12-27 Dow Agrosciences Llc Novel dna sequences, vectors and proteins of avian influenza hemagglutinin
US20080241188A1 (en) * 2007-03-30 2008-10-02 Zeon Corporation Turkey herpesvirus vectored recombinant containing avian influenza genes
BRPI0810865A2 (pt) * 2007-04-28 2017-05-09 Fraunhofer Usa Inc antígenos de tripanossoma, composições vacinais, e métodos relacionados
RU2499053C2 (ru) * 2007-06-15 2013-11-20 Медикаго Инк. Способ синтеза белка с модифицированным профилем n-гликозилирования в растениях
KR100964462B1 (ko) * 2007-07-10 2010-06-16 성균관대학교산학협력단 형질전환 식물 유래의 조류독감 바이러스 백신 및 그 제조방법
CA2692933C (en) * 2007-07-11 2016-10-18 Fraunhofer Usa, Inc. Yersinia pestis antigens, vaccine compositions, and related methods
CA2615372A1 (en) * 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
US20110059130A1 (en) * 2007-08-20 2011-03-10 Fraunhofer Usa, Inc. Prophylactic and therapeutic influenza vaccines, antigens, compositions and methods
CN101978066A (zh) * 2007-11-27 2011-02-16 麦迪卡格公司 表达血凝素之转基因植物中生产的重组流感病毒样颗粒(vlp)
KR101956910B1 (ko) * 2008-01-21 2019-03-12 메디카고 인코포레이티드 헤마글루티닌을 발현하는 트랜스제닉 식물에서 생산된 재조합 인플루엔자 바이러스-유사 입자(ＶＬＰｓ)
CN102089432A (zh) * 2008-07-08 2011-06-08 麦迪卡格公司 可溶性重组流感抗原
ES2593277T3 (es) 2008-07-18 2016-12-07 Medicago Inc. Nuevo epítopo de inmunización contra el virus de la influenza
US8734803B2 (en) 2008-09-28 2014-05-27 Ibio Inc. Humanized neuraminidase antibody and methods of use thereof
US9233148B2 (en) * 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
WO2010117786A1 (en) 2009-03-30 2010-10-14 Mount Sinai School Of Medicine Of New York University Influenza virus vaccines and uses thereof
BRPI1015053A2 (pt) * 2009-06-24 2019-07-09 Medicago Inc partículas similares a vírus da influenza quiméricas compreendendo hemaglutinina
TR201803560T4 (tr) 2009-09-22 2019-01-21 Medicago Inc Bitkiden türetilen proteinlerin hazırlanma metotları.
EP2483307A1 (en) 2009-09-29 2012-08-08 Fraunhofer USA, Inc. Influenza hemagglutinin antibodies, compositions, and related methods
US10633667B2 (en) 2009-12-28 2020-04-28 Boehringer Ingelheim Animal Health USA Inc. Recombinant NDV antigen and uses thereof
US9012197B2 (en) 2009-12-28 2015-04-21 Merial, Inc. Production of hemagglutinin-neuraminidase protein in microalgae
KR20120132506A (ko) 2010-02-18 2012-12-05 마운트 시나이 스쿨 오브 메디슨 인플루엔자 바이러스 질환의 예방 및 치료에 사용되는 백신
US9708373B2 (en) 2010-03-30 2017-07-18 Icahn School Of Medicine At Mount Sinai Influenza virus vaccine and uses thereof
KR20130122947A (ko) 2010-10-27 2013-11-11 필립모리스 프로덕츠 에스.에이. 팽창성 베드 크로마토그래피를 사용하여 식물로부터 바이러스 유사 입자를 포획하는 방법
TWI620816B (zh) 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
CN108164602A (zh) 2011-09-20 2018-06-15 西奈山医学院 流感病毒疫苗及其应用
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
CA2850407C (en) * 2011-09-30 2021-11-23 Medicago Inc. Increasing virus-like particle yield in plants
CN108641002A (zh) 2012-12-18 2018-10-12 西奈山伊坎医学院 流感病毒疫苗及其用途
WO2014159960A1 (en) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
WO2014153674A1 (en) 2013-03-28 2014-10-02 Medicago Inc. Influenza virus-like particle production in plants
US11441150B2 (en) 2014-01-10 2022-09-13 Medicago Inc. CPMV enhancer elements
JP2018504412A (ja) 2015-01-23 2018-02-15 アイカーン スクール オブ メディシン アット マウント サイナイ インフルエンザウイルスワクチン接種レジメン
US11266734B2 (en) 2016-06-15 2022-03-08 Icahn School Of Medicine At Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
CA3058652A1 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
WO2019246363A1 (en) 2018-06-21 2019-12-26 Icahn School Of Medicine At Mount Sinai Mosaic influenza virus hemagglutinin polypeptides and uses thereof
EP4392565A4 (en) * 2021-08-24 2025-02-12 Futuragene Israel Ltd. SEQUENCES AND PROMOTERS FOR USE IN PLANT CELLS AND METHODS FOR THE PRODUCTION AND USE OF SUCH SEQUENCES
WO2023237726A1 (en) * 2022-06-10 2023-12-14 Pantarhei Oncology B.V. An intracellular tumor-specific variant of human zona pellucida glycoprotein 3 and nucleic acids coding therefor for use in the treatment of cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339307C (en) * 1988-09-06 1997-08-19 Roy Curtiss, Iii Oral immunization by transgenic plants
US20010053367A1 (en) * 1991-08-26 2001-12-20 Prodigene, Inc. Vaccines expressed in plants
US5612487A (en) * 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
US6034298A (en) * 1991-08-26 2000-03-07 Prodigene, Inc. Vaccines expressed in plants
US5426108A (en) * 1993-11-10 1995-06-20 American Cyanamid Company Antibiotic 31F508 ALPHA1, ALPHA2, BETA1 and BETA2
AU691707B2 (en) * 1994-10-24 1998-05-21 The Administrators Of The Tulane Eductional Fund Oral immunization with transgenic plants
EP0770397B1 (en) * 1995-10-18 2004-04-21 Akzo Nobel N.V. Newcastle disease virus combination vaccine
US6395964B1 (en) * 1995-10-24 2002-05-28 The Texas A&M University System Oral immunization with transgenic plants
EP0974660A1 (en) * 1998-06-19 2000-01-26 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Newcastle disease virus infectious clones, vaccines and diagnostic assays
WO2002000169A2 (en) * 2000-06-26 2002-01-03 The United States Of America, As Represented By The Secretary Of Agriculture Production of vaccines using transgenic plants
JP4500493B2 (ja) 2001-04-13 2010-07-14 ボイス トンプソン インステイテュート フォア プラント リサーチ 安定なトランスジェニック植物医薬品の作製方法および組成物ならびに避妊薬としてのその使用

Also Published As

Publication number Publication date
CN100393870C (zh) 2008-06-11
AU2004235813B2 (en) 2010-07-29
EP1620550B1 (en) 2010-07-07
US7132291B2 (en) 2006-11-07
ATE473271T1 (de) 2010-07-15
WO2004098533A2 (en) 2004-11-18
NZ543348A (en) 2008-08-29
CA2524293A1 (en) 2004-11-18
EP1620550A4 (en) 2006-06-14
US7407802B2 (en) 2008-08-05
US20090017065A1 (en) 2009-01-15
AU2004235813A1 (en) 2004-11-18
DE602004028004D1 (de) 2010-08-19
WO2004098533A3 (en) 2005-08-04
BRPI0410340A (pt) 2006-05-30
ZA200508930B (en) 2007-03-28
US20080076177A1 (en) 2008-03-27
CN1788077A (zh) 2006-06-14
US20050048074A1 (en) 2005-03-03
KR20060035596A (ko) 2006-04-26
EP1620550A2 (en) 2006-02-01

Similar Documents

Publication Publication Date Title
AR044246A1 (es) Vectores y celulas para la preparacion de composiciones inmunoprotectoras derivadas de plantas transgenicas
AR111197A2 (es) AXMI-031, AXMI-039, AXMI-040 Y AXMI-049, UNA FAMILIA DE GENES DE d-ENDOTOXINAS, Y MÉTODOS PARA USARLOS
CY1121353T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
AR091299A1 (es) Polinucleotidos y polipeptidos aislados y metodos para utilizarlos para mejorar el rendimiento de las plantas
AR086243A1 (es) Polipeptidos y polinucleotidos aislados y metodos para su uso, para aumentar el rendimiento, la biomasa, el indice de crecimiento, el vigor, el contenido de aceite, la tolerancia al estres abiotico de las plantas y la eficiencia en el uso del nitrogeno
AR078052A1 (es) Gen plaguicida axmi 205 de chromobacterium y metodos para su uso
MX2019004610A (es) Composiciones y métodos para alterar la floración y arquitectura de planta para mejorar el potencial de rendimiento.
AR036818A1 (es) Composiciones y metodos para promover resistencia a nematodos en plantas
AR087480A2 (es) Metodo para preparar una planta de cebada que posee una mutacion en el gen lox-1, composiciones de malta y metodos de produccion
MY161855A (en) Production of modified fatty acids in plants through rdna targeted integration of heterologous genes
AR061294A1 (es) Plantas con caracteristicas de crecimiento mejoradas y metodo para prepararlas
AR053893A1 (es) Plantas con caracteristicas de crecimiento mejorado y metodo para desarrollar las mismas
AR057884A1 (es) Plantas con caracteristicas de crecimiento mejoradas y un metodo para desarrollarlas
AR126966A2 (es) Una planta transgénica que presenta un rendimiento mejorado y tolerancia al estrés abiótico, y método de obtención de dicha planta
AR066813A1 (es) Vector poxvirus recombinante de mapache (rrcnv) vacuna recombinante contra la rabia plasmido pfd2003-gpv-pv y metodos para hacer el vector poxvirus recombinante de mapache y para inducir una respuesta inmune protectora contra la rabia
AR096405A2 (es) Molécula de ácido nucleico que confiere tolerancia al herbicida dicamba, métodos para producir plantas tolerantes a dicamba y para métodos para controlar el crecimiento de malezas
CY1112575T1 (el) Βελτιωμενα αδρανοποιημενα εμβολια fcv
CN1046463A (zh) 无毒微生物及其应用
BRPI0907472A8 (pt) Uso de um gene rdl1 de planta ou sua proteína rdl1 codificada, vetor de expressão que contém um promotor heterólogo, célula hospedeira transgênica, bem como método para a produção de uma planta transgênica, uso da planta transgênica e método para a produção de sementes de planta
WO2018231078A2 (es) Obtención de una salmonela enteritidis tipo rugosa y sus modificaciones genéticas para uso como vacuna aviar
AR069884A1 (es) Metodos para empacar vectores de virus de estomatitis vesicular de propagacion defectuosa
Sabovljevic et al. In vitro micropropagation of rare and endangered moss Entosthodon hungaricus (Funariaceae)
PE20061169A1 (es) Cepas de empaque bacteriano para la generacion y produccion de nucleocapsides de arn de doble hebra
ES2571338T3 (es) Plantas madereras con características de desarrollo mejoradas y método para su obtención
BRPI0508953A (pt) método para melhorar as caracterìsticas de crescimento de planta, plantas, construto, método para a produção de uma planta transgênica, planta transgênica, partes de uma planta capazes de serem colhidas, e, uso de uma s3a ou de um ácido nucleico codificador de s3a

Legal Events

Date Code Title Description
FB Suspension of granting procedure